Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health
2023-03-01
|
| Series: | Blood Science |
| Online Access: | http://journals.lww.com/10.1097/BS9.0000000000000137 |
| _version_ | 1827805087174492160 |
|---|---|
| author | Qiang Li Zhihuan Yang Kuo Fang Shuning Wei Jiali Sun Wei Liu Xiaojuan Chen Wenyang Huang Guangji Zhang Yin Shi Yuntao Liu Xiaoyuan Gong Fang Liu Xueli Zhou Jianxiang Wang Ying Wang |
| author_facet | Qiang Li Zhihuan Yang Kuo Fang Shuning Wei Jiali Sun Wei Liu Xiaojuan Chen Wenyang Huang Guangji Zhang Yin Shi Yuntao Liu Xiaoyuan Gong Fang Liu Xueli Zhou Jianxiang Wang Ying Wang |
| author_sort | Qiang Li |
| collection | DOAJ |
| first_indexed | 2024-03-11T21:20:34Z |
| format | Article |
| id | doaj.art-168d1f70c20845fe9399122ac40a03c6 |
| institution | Directory Open Access Journal |
| issn | 2543-6368 |
| language | English |
| last_indexed | 2024-03-11T21:20:34Z |
| publishDate | 2023-03-01 |
| publisher | Wolters Kluwer Health |
| record_format | Article |
| series | Blood Science |
| spelling | doaj.art-168d1f70c20845fe9399122ac40a03c62023-09-28T07:06:17ZengWolters Kluwer HealthBlood Science2543-63682023-03-0151626510.1097/BS9.0000000000000137202303000-00008Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapyQiang Li0Zhihuan Yang1Kuo Fang2Shuning Wei3Jiali Sun4Wei Liu5Xiaojuan Chen6Wenyang Huang7Guangji Zhang8Yin Shi9Yuntao Liu10Xiaoyuan Gong11Fang Liu12Xueli Zhou13Jianxiang Wang14Ying Wang15a State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinaa State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem,Tianjin Key Laboratory of Cell Therapy for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, Chinahttp://journals.lww.com/10.1097/BS9.0000000000000137 |
| spellingShingle | Qiang Li Zhihuan Yang Kuo Fang Shuning Wei Jiali Sun Wei Liu Xiaojuan Chen Wenyang Huang Guangji Zhang Yin Shi Yuntao Liu Xiaoyuan Gong Fang Liu Xueli Zhou Jianxiang Wang Ying Wang Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy Blood Science |
| title | Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy |
| title_full | Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy |
| title_fullStr | Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy |
| title_full_unstemmed | Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy |
| title_short | Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy |
| title_sort | reduced abo blood group antibody titers in patients after cd19 car t cell therapy |
| url | http://journals.lww.com/10.1097/BS9.0000000000000137 |
| work_keys_str_mv | AT qiangli reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT zhihuanyang reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT kuofang reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT shuningwei reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT jialisun reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT weiliu reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT xiaojuanchen reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT wenyanghuang reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT guangjizhang reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT yinshi reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT yuntaoliu reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT xiaoyuangong reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT fangliu reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT xuelizhou reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT jianxiangwang reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy AT yingwang reducedabobloodgroupantibodytitersinpatientsaftercd19cartcelltherapy |